HAR1A and ovarian serous adenocarcinoma: For serous ovarian cancer patients treated with platin, five lncRNAs including HAR1A, LINC00886, LINC01139, LINC-PINT, DNM3OS were significantly associated with PFS (Figure S14 and Table S11).